Berenguer, J., Gil‐Martin, Á., Jarrin, I., Moreno, A., Dominguez, L., Montes, M., Aldámiz‐Echevarría, T., Téllez, M. J., Santos, I., Benitez, L., Sanz, J., Ryan, P., Gaspar, G., Alvarez, B., Losa, J. E., Torres‐Perea, R., Barros, C., Martin, J. V. S., Arponen, S., de Guzmán, M. T., Monsalvo, R., Vegas, A., Garcia‐Benayas, M. T., Serrano, R., Gotuzzo, L., Menendez, M. A., Belda, L. M., Malmierca, E., Calvo, M. J., Cruz‐Martos, E., & González‐García, J. J. (2018). all‐oral direct‐acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV–coinfected subjects in real‐world practice: Madrid coinfection registry findings. Hepatology, 68(1), 32–47. http://access.bl.uk/ark:/81055/vdc_100066434084.0x000045